Coherus Oncology, Inc 10-K for FY2020
Coherus Oncology, Inc. (CHRS)
10-K
2021-02-25
For: 2020-12-31
View Original
Added on
April 09, 2026
About this 10-K
Coherus Oncology, Inc filed this 10-K on February 25, 2021, covering the fiscal year ended December 31, 2020 (FY2020).
Headline figures
Fiscal year ended December 31, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $475.82M
- up 33.6% from $356.07M a year earlier
- Net income
- $132.24M
- up 47.2% from net income of $89.83M a year earlier
- Diluted EPS
- $1.62
- up 31.7% from $1.23 a year earlier